Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Med. oral patol. oral cir. bucal (Internet) ; 18(1): 93-99, ene. 2013. ilus
Article in English | IBECS | ID: ibc-108228

ABSTRACT

The association between osteoporosis and jawbones remains an argument of debate. Both osteoporosis and periodontal diseases are bone resorptive diseases; it has been hypothesized that osteoporosis could be a risk factor for the progression of periodontal disease and vice versa. Hypothetical models linking the two conditions exist: in particular, it is supposed that the osteoporosis-related bone mass density reduction may accelerate alveolar bone resorption caused by periodontitis, resulting in a facilitated periodontal bacteria invasion. Invading bacteria, in turn, may alter the normal homeostasis of bone tissue, increasing osteoclastic activity and reducing local and systemic bone density by both direct effects (release of toxins) and/or indirect mechanisms (release of inflammatory mediators). Current evidence provides conflicting results due to potential biases related to study design, samples size and endpoints. The aim of this article is to review and summarize the published literature on the associations between osteoporosis and different oral conditions such as bone loss in the jaws, periodontal diseases, and tooth loss. Further well-controlled studies are needed to better elucidate the inter-relationship between systemic and oral bone loss and to clarify whether dentists could usefully provide early warning for osteoporosis risk (AU)


No disponible


Subject(s)
Humans , Osteoporosis/complications , Periodontitis/complications , Alveolar Bone Loss/complications , Mouth, Edentulous/complications , Bone Density/physiology , Risk Factors
2.
Med Oral Patol Oral Cir Bucal ; 18(1): e93-9, 2013 Jan 01.
Article in English | MEDLINE | ID: mdl-23229255

ABSTRACT

The association between osteoporosis and jawbones remains an argument of debate. Both osteoporosis and periodontal diseases are bone resorptive diseases; it has been hypothesized that osteoporosis could be a risk factor for the progression of periodontal disease and vice versa. Hypothetical models linking the two conditions exist: in particular, it is supposed that the osteoporosis-related bone mass density reduction may accelerate alveolar bone resorption caused by periodontitis, resulting in a facilitated periodontal bacteria invasion. Invading bacteria, in turn, may alter the normal homeostasis of bone tissue, increasing osteoclastic activity and reducing local and systemic bone density by both direct effects (release of toxins) and/or indirect mechanisms (release of inflammatory mediators). Current evidence provides conflicting results due to potential biases related to study design, samples size and endpoints. The aim of this article is to review and summarize the published literature on the associations between osteoporosis and different oral conditions such as bone loss in the jaws, periodontal diseases, and tooth loss. Further well-controlled studies are needed to better elucidate the inter-relationship between systemic and oral bone loss and to clarify whether dentists could usefully provide early warning for osteoporosis risk.


Subject(s)
Mandible , Osteoporosis/complications , Periodontal Diseases/complications , Humans
3.
Gerodontology ; 29(2): e1207-14, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22612839

ABSTRACT

BACKGROUND: Langerhans cell histiocytosis (LCH) is a proliferative disease of histiocyte-like cells that generally affects children; LCH onset is rare in adults; immunohistochemistry is essential to obtain the correct diagnosis, and treatment protocols are controversial. OBJECTIVE: To describe two new cases of adult onset oral LCH. CASE REPORTS: Case 1: a 71-year-old woman, complaining of diffuse oral pain, presented with erythematous mucosal lesions; the panoramic radiograph and CT scan showed multiple mandible radiolucent areas. Immunohistochemical assay for S-100, CD1a and langerin test was essential in reaching the correct diagnosis. Case 2: a 77-year-old female patient presented with a non-painful, non-bleeding, slightly elevated erythematous palatal lesion of 6 months duration, together with a genital vulvar lesion of uncertain nature. The pathology confirmed the diagnosis of LCH. Many therapies (etoposid, radiotherapy) could induce only a clinical partial remission; Cladribine induced a complete recovery. CONCLUSION: The first case was difficult to diagnose: the clinical presentation and course of the disease (LCH) in the elderly are multiple and unpredictable. An immunohistochemistry study is often essential to obtain the correct diagnosis. The second case required several therapeutic interventions: even though some cases regress spontaneously, others require systemic chemotherapy.


Subject(s)
Histiocytosis, Langerhans-Cell/diagnosis , Mandibular Diseases/diagnosis , Mouth Diseases/diagnosis , Palate/pathology , Aged , Antigens, CD/analysis , Antigens, CD1/analysis , Antineoplastic Agents/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Cladribine/therapeutic use , Diagnosis, Differential , Erythema/diagnosis , Etoposide/therapeutic use , Female , Humans , Lectins, C-Type/analysis , Mannose-Binding Lectins/analysis , Periodontal Diseases/diagnosis , Radiotherapy, Adjuvant , S100 Proteins/analysis , Vulvar Diseases/diagnosis
4.
Med Sci Monit ; 17(4): PH23-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21455116

ABSTRACT

BACKGROUND: The risks/benefits balance of hormone replacement therapy (HRT) is controversial. The aim of this study was to assess the periodontal status of a postmenopausal women group receiving HRT and to determine the effects of HRT on clinical measures of periodontal disease. MATERIAL/METHODS: Ninety-one postmenopausal women, 52 taking HRT (HRT+) and 39 not taking HRT (HRT-), completed the study. Clinical parameters measured included visible supragingival plaque, probing pocket depth (PD) and clinical attachment level (CAL). Gingival status was recorded as gingival bleeding on probing (BOP). Previous oral contraceptive use and current and past smoking status were also assessed. RESULTS: Data indicated that PD and CAL were not significantly different between HRT+ patients and HRT- patients (P=0.8067 and P=0.1627, respectively). The HRT+ group exhibited significantly lower visible plaque levels compared to the control group (P<0.0001). The percentage of gingival sites with positive BOP was significantly lower in the HRT+ group compared to the HRT- group (34.85% vs. 65.15%; P=0.0007). Plaque accumulation was also tested in ANCOVA as a possible explanatory variable for the differences observed in gingival bleeding. The ANCOVA showed no significant differences in gingival bleeding between HRT+ and HRT- women (P=0.4677). No significant differences in past smoking status and oral contraceptive use were detected between HRT+ and HRT- women (P=0.9999 and P=0.0845, respectively). CONCLUSIONS: These findings indicated that long-term HRT was not associated with relevant effects on periodontal status and clinical measures of periodontal disease, thus suggesting that HRT may not confer protection against periodontitis in postmenopausal women.


Subject(s)
Estrogen Replacement Therapy , Periodontium/pathology , Female , Humans , Middle Aged
5.
Eur J Intern Med ; 21(6): 496-502, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21111933

ABSTRACT

During past decades the relationship between dentistry and internal medicine and especially the concept of the so-called focal infection theory have long been a matter of debate. The pathogenesis of focal diseases has been classically attributed to dental pulp pathologies and periapical infections. Nonetheless, in recent years, their role is being dismissed while increasing interest is being devoted to the possible associations between periodontal infection and systemic diseases. In fact, periodontal pathogens and their products, as well as inflammatory mediators produced in periodontal tissues, might enter the bloodstream, causing systemic effects and/or contributing to systemic diseases. On the basis of this mechanism, chronic periodontitis has been suggested as a risk factor for cardiovascular diseases associated with atherosclerosis, bacterial endocarditis, diabetes mellitus, respiratory disease, preterm delivery, rheumatoid arthritis, and, recently, osteoporosis, pancreatic cancer, metabolic syndrome, renal diseases and neurodegenerative diseases such as Alzheimer's disease. Various hypotheses, including common susceptibility, systemic inflammation, direct bacterial infection and cross-reactivity, or molecular mimicry, between bacterial antigens and self-antigens, have been postulated to explain these relationships. In this scenario, the association of periodontal disease with systemic diseases has set the stage for introducing the concept of periodontal medicine. This narrative review summarizes the evolution of focal infection theory up to the current pathophysiology of periodontal disease, and presents an update on the relationships between chronic periodontitis and systemic diseases.


Subject(s)
Chronic Disease/epidemiology , Chronic Periodontitis/epidemiology , Dentistry , Internal Medicine , Chronic Periodontitis/immunology , Humans , Risk Factors
6.
Int J Dermatol ; 48(10): 1049-52, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19775398

ABSTRACT

BACKGROUND: Desquamative gingivitis (DG) is a descriptive term used to indicate epithelial desquamation, erythema, erosions, and/or vesiculobullous lesions of the gingiva. DG is commonly associated with several mucocutaneous disorders and systemic conditions that may carry a poor prognosis and high morbidity; however, there are no clear data concerning the frequency of these disease associations. METHODS: We investigated the epidemiologic features of DG in 125 patients and compared our findings with information from a literature review. RESULTS: In our series, 88% of patients with DG had one of the following three disorders: oral lichen planus (OLP), mucous membrane pemphigoid (MMP), or pemphigus vulgaris. The most common cause of DG was OLP (75% of patients). 22% of patients had isolated gingival involvement, and there were diffuse gingival lesions in 57% of patients. Symptoms ranged from none (1%) to severe pain (10%). There was extra-oral involvement of skin in 14% of patients, conjunctiva in 7%, genital mucosa in 26%, and internal organs in 3%. Our study showed MMP to be associated with DG in only a small percentage of patients (9%); this finding may be related to the patient population, epidemiology of the specific disease, and referral and/or past diagnostic bias. CONCLUSION: Based on our series and recent reports, OLP seems to be the most common cause of DG.


Subject(s)
Gingivitis/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult
7.
Immun Ageing ; 6: 12, 2009 Sep 08.
Article in English | MEDLINE | ID: mdl-19737378

ABSTRACT

A Symposium regarding the Pathophysiology of Successful and Unsuccessful Ageing was held in Palermo, Italy on 7-8 April 2009. Three lectures from that Symposium by G. Campisi, L. Ginaldi and F. Licastro are here summarized. Ageing is a complex process which negatively impacts on the development of various bodily systems and its ability to function. A long life in a healthy, vigorous, youthful body has always been one of humanity's greatest dreams. Thus, a better understanding of the pathophysiology of age-related diseases is urgently required to improve our understanding of maintaining good health in the elderly and to program possible therapeutic intervention.

8.
Med Sci Monit ; 15(6): CS95-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19478707

ABSTRACT

BACKGROUND: Eosinophilic granuloma (EG) is a clinical variant of the Langerhans cell histiocytosis (LCH) characterized by unifocal or multifocal bone lesions which predominantly affects children, adolescents, and young adults. CASE REPORT: A case is reported of a 13-year-old Caucasian boy who presented unifocal EG in the mandible as the first clinic manifestation. Radiographic examination and skeletal scintigraphy revealed a further localization with an osteolytic lesion in the right femur. The therapeutic protocol used for the mandibular lesion included causal periodontal therapy, extraction of the compromised teeth, alveolar curettage, and intralesional injections of corticosteroids, in correspondence with femoral and mandibular bone lesions. CONCLUSIONS: Early diagnosis of LCH is considered an important factor which can improve the patient's prognosis and quality of life and also the cost-effectiveness of therapy. Dentists could play a fundamental role in the diagnosis and management of EG. The aim of the treatment is to eradicate EG lesions and provide adequate oral rehabilitation after the tooth loss. A careful multidisciplinary follow-up program is mandatory to identify any signs of local recurrence or dissemination.


Subject(s)
Eosinophilic Granuloma/pathology , Adolescent , Bone Resorption/complications , Bone Resorption/diagnostic imaging , Eosinophilic Granuloma/complications , Eosinophilic Granuloma/diagnostic imaging , Follow-Up Studies , Humans , Male , Osteolysis/complications , Osteolysis/diagnostic imaging , Radiography
9.
Recenti Prog Med ; 99(9): 422-31, 2008 Sep.
Article in Italian | MEDLINE | ID: mdl-19044250

ABSTRACT

The aim of this paper was to provide an update on necrotizing periodontal disease (NPD). Original papers on this subject published in English from January 2002 until December 2007 were located in MEDLINE/PubMed database. Other sources were taken from the references of the selected papers. The clinical features of NPD include necrosis and ulceration of the gingival margin and the interdental papilla. These signs are usually associated to halitosis, pain, spontaneous gingival bleeding, malaise and sometimes fever. NPD usually occurs in developing countries, but few cases have also been reported in industrialized nations. The predisposing factors associated with the onset and progression of NPD include immunodeficiency, malnutrition, stress, smoking and poor oral hygiene. The treatment of NPD is dependent on the presence of pain and gingival necrosis. Systemic antibiotic therapy is recommended when a systemic disease is suspected.


Subject(s)
Periodontal Diseases , Humans , Necrosis , Periodontal Diseases/diagnosis , Periodontal Diseases/etiology , Periodontal Diseases/therapy , Periodontium/pathology
10.
J Periodontol ; 79(1): 4-24, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18166088

ABSTRACT

The term desquamative gingivitis (DG) refers to a clinical manifestation that can be caused by several disorders. Many of them are immunologically mediated; in addition to the oral cavity, they can affect extraoral mucocutaneous sites, e.g., larynx, conjunctiva, esophagus, nasal and genital mucosa, and the skin. The degree of oral, periodontal, and systemic involvement determines the overall morbidity and, sometimes, the mortality of these disorders. We comprehensively review disorders commonly associated with DG and highlight diagnostic pathways, guidelines for differential diagnosis, and oral, periodontal, and systemic implications. More rare conditions are reviewed as well. Mucous membrane pemphigoid, oral lichen planus, and pemphigus vulgaris are responsible for the majority of cases of DG. In addition, other uncommon disorders should be considered. Accurate clinical, histologic, and serologic investigations are often required to differentiate among DG-associated disorders, provide adequate therapy, and improve the prognosis of patients.


Subject(s)
Gingivitis/diagnosis , Blister/pathology , Diagnosis, Differential , Erythema/pathology , Erythema Multiforme/diagnosis , Gingivitis/immunology , Gingivitis/pathology , Humans , Lichen Planus, Oral/diagnosis , Pemphigoid, Benign Mucous Membrane/diagnosis , Pemphigus/diagnosis , Prognosis
11.
Recenti Prog Med ; 98(7-8): 426-32, 2007.
Article in Italian | MEDLINE | ID: mdl-17685192

ABSTRACT

The present paper reviews relationship between chronic periodontitis and cardiovascular diseases. Original papers on this subject, published in English in the period between 2001 and the first semester 2006, were located in the MEDLINE/PubMed database. Additional studies were obtained by searching reference lists of previously published papers. Periodontal infection provides a chronic reservoir of inflammatory mediators and cytokines, lipopolysaccharide, which contribute to the formation of atheroma. Moreover, periodontal pathogens can penetrate the epithelial barrier of the periodontal tissues and reach the blood stream, carrying out a local atherogenic activity. Some studies indicated that periodontal treatment could result in reduction of cardiovascular events. If these results are confirmed in further intervention studies, the prevention and the treatment of periodontitis should be considered as factors able to avoid or reduced the onset and/or evolution of cardiovascular diseases.


Subject(s)
Cardiovascular Diseases/microbiology , Periodontitis/microbiology , Atherosclerosis/microbiology , Cardiovascular Diseases/physiopathology , Chronic Disease , Coronary Artery Disease/microbiology , Humans , Periodontal Diseases/microbiology , Periodontal Diseases/physiopathology , Periodontitis/physiopathology , Risk Factors
12.
J Dent ; 35(6): 503-8, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17350152

ABSTRACT

UNLABELLED: Sugar-free chewing gum has been claimed to be a useful means of reducing dental plaque accumulation. The incorporation of additives, such as enzymes, abrasives and divalent metal ions, into gum formulations might improve their antiplaque activity, particularly at the buccal and lingual surfaces of the teeth. OBJECTIVES: The aim of this study was to investigate the plaque inhibitory effects of three sugar-free chewing gums each containing lactoperoxidase (LP), micro granules of silicon dioxide (SD), and zinc gluconate (ZG). METHODS: The study was an observer-masked, randomized cross-over design balanced for carryover effects, involving 12 healthy volunteers in a 4-day plaque regrowth model. An additive-free (AF) gum served as positive/negative control for occlusal and smooth surfaces, respectively. On day 1, subjects received professional prophylaxis, suspended oral hygiene measures, and commenced chewing their allocated product. Gum chewing was one piece chewed for 30min 4 times a day. On day 5, subjects were scored for disclosed plaque. RESULTS: There were no significant differences in antiplaque activity of the gums tested, neither for the smooth nor for the occlusal surfaces (P=0.447 and P=0.418, respectively). Similar results were obtained for the anterior and posterior sites of smooth surfaces (P>0.05), and for the lower and upper sites of occlusal surfaces (P=0.451 and P=0.53, respectively). CONCLUSIONS: These findings suggest that the chewing gums containing LP, SD and ZG would provide no plaque inhibitory effects on smooth surfaces. The gums containing these additives, therefore, should not be recommended as adjuncts to mechanical oral hygiene.


Subject(s)
Chewing Gum , Dental Plaque/prevention & control , Adult , Cross-Over Studies , Dental Plaque/pathology , Dental Plaque Index , Erythrosine , Female , Fluorescent Dyes , Gluconates/therapeutic use , Humans , Lactoperoxidase/therapeutic use , Male , Silicon Dioxide/therapeutic use , Single-Blind Method , Sweetening Agents/therapeutic use , Time Factors , Zinc/therapeutic use
13.
Med Oral Patol Oral Cir Bucal ; 12(1): E19-25, 2007 Jan 01.
Article in English | MEDLINE | ID: mdl-17195822

ABSTRACT

Severe gingival overgrowth is one of the most frequent side effects in renal transplant patients associated with assumption of cyclosporine A. Several associations with age, sex, dosage, duration of therapy or interval since transplantation have been hypothesized. The introduction of alternative immunosuppressant drugs have been suggested to permit better long-term transplant outcomes and a decrease in incidence of gingival overgrowth. The aim of the present paper is to summarize current knowledge regarding aetiology, pathogenesis and management of gingival overgrowth induced by Cyclosporine A.


Subject(s)
Cyclosporine/adverse effects , Gingival Overgrowth/chemically induced , Immunosuppressive Agents/adverse effects , Kidney Transplantation , Postoperative Complications/chemically induced , Humans
14.
Med. oral patol. oral cir. bucal (Internet) ; 12(1): E19-E25, ene. 2007. tab
Article in En | IBECS | ID: ibc-053416

ABSTRACT

El sobrecrecimiento gingival severo es uno de los efectos adversos más frecuentes en los pacientes con transplante renal asociado al suministro de ciclosporina A. Se han realizado hipótesis sobre diversas asociaciones con la edad, sexo, dosis, duración de la terapia o intervalo desde el transplante. Se ha propuesto la introducción de la alternativa de drogas inmunosupresoras para permitir mejores resultados a largo plazo del transplante y la disminución en la incidencia de sobrecrecimiento gingival. El objetivo del presente estudio es resumir el conocimiento actual, observando la etiología, patogénesis y dirección del sobrecrecimiento gingival inducido por la ciclosporina A


Severe gingival overgrowth is one of the most frequent side effects in renal transplant patients associated with assumption of cyclosporine A. Several associations with age, sex, dosage, duration of therapy or interval since transplantation have been hypothesized. The introduction of alternative immunosuppressant drugs have been suggested to permit better long-term transplant outcomes and a decrease in incidence of gingival overgrowth. The aim of the present paper is to summarize current knowledge regarding aetiology, pathogenesis and management of gingival overgrowth induced by Cyclosporine A


Subject(s)
Humans , Cyclosporine/adverse effects , Gingival Overgrowth/chemically induced , Immunosuppressive Agents/adverse effects , Kidney Transplantation , Postoperative Complications/chemically induced
15.
J Periodontol ; 77(2): 248-56, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16460251

ABSTRACT

BACKGROUND: Due to the side effects of chlorhexidine digluconate (CHX) mouthrinsing, a spray has been proposed as an alternative method of CHX delivery to the oral cavity. The aim of this study was to investigate the plaque inhibitory effects of CHX, cetylpyridinium chloride (CPC), and triclosan (TRN) delivered by sprays and mouthrinses. METHODS: The study was an observer-masked, randomized cross-over design balanced for carryover effects, involving 15 healthy volunteers in a 4-day plaque regrowth model. Products being tested (0.2% CHX, 0.12% CHX, 0.05% CPC, and 0.03% TRN) were used both as sprays and mouthrinses. A saline solution served as a negative control. On day 1, subjects received professional prophylaxis, suspended oral hygiene measures, and commenced using their allocated products. On day 5, subjects were scored for disclosed plaque. RESULTS: CHX sprays (P<0.01) were the most effective sprays in preventing plaque regrowth, without significant differences between the two concentrations tested (P>0.05). TRN spray showed a significant inhibition of plaque regrowth in comparison to the negative control (P<0.05). CPC spray did not differ from saline spray (P>0.05). A similar trend of efficacy was detected for rinses. Although the effect on plaque regrowth observed with CHX rinses was superior to that of CHX sprays (P<0.0003), the latter did not cause side effects (P>0.2). CONCLUSIONS: These findings, together with those from clinical trials, suggest that the CHX-containing sprays may represent an effective alternative to CHX rinses when mechanical oral hygiene has to be avoided in restricted areas. On the contrary, the TRN and CPC sprays showed little or no plaque inhibitory effects.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Cetylpyridinium/administration & dosage , Chlorhexidine/analogs & derivatives , Dental Plaque/prevention & control , Mouthwashes/administration & dosage , Triclosan/administration & dosage , Adult , Aerosols , Anti-Infective Agents, Local/adverse effects , Cetylpyridinium/adverse effects , Chlorhexidine/administration & dosage , Chlorhexidine/adverse effects , Coloring Agents , Cross-Over Studies , Dental Plaque/pathology , Dental Prophylaxis , Female , Humans , Male , Mouthwashes/adverse effects , Observer Variation , Oral Hygiene , Reproducibility of Results , Single-Blind Method , Sodium Chloride , Triclosan/adverse effects
16.
J Periodontol ; 75(6): 852-7, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15295952

ABSTRACT

BACKGROUND: Chlorhexidine (CHX)-containing mouthrinses are recommended as adjuncts to mechanical oral hygiene. The problem associated with side effects, however, has stimulated the search for alternative antiplaque agents. The aim of this study was to investigate the plaque inhibitory effects of two mouthrinses containing amine fluoride/stannous fluoride (ASF) and antimicrobial host proteins (lactoperoxidase, lysozyme and lactoferrin; LLL), respectively. METHODS: The study was an observer-masked, randomized 4x4 Latin square cross-over design balanced for carryover effects, involving 12 healthy volunteers in a 4-day plaque regrowth model. A 0.12% CHX mouthrinse and a saline solution served as positive and negative controls, respectively. On day 1, subjects received professional prophylaxis, suspended oral hygiene measures, and commenced rinsing with their allocated rinses. On day 5, subjects were scored for disclosed plaque. RESULTS: The ASF rinse showed a significant inhibition of plaque regrowth in comparison to both saline and LLL solutions, but the lowest plaque indices were obtained with the CHX formulation (P<0.01). There were no significant differences between LLL rinse and saline (P>0.05). Such pattern of efficacy was the same in anterior and posterior teeth and in vestibular and lingual surfaces as well, with the exception of the lingual anterior surfaces. In these sites, differences between the CHX and ASF rinses were not significant (P>0.05). A significantly higher prevalence of side effects was found in subjects using the CHX product (P<0.0042). CONCLUSIONS: Although the effect on plaque regrowth observed with 0.12% CHX rinsing was superior to that with ASF, the ASF rinse was not associated with side effects. These findings, together with those from long-term trials, suggest that the ASF rinse may represent an effective alternative to CHX rinse as an adjunct to oral hygiene. On the contrary, the LLL rinse did not significantly inhibit plaque regrowth.


Subject(s)
Dental Plaque/drug therapy , Mouthwashes/therapeutic use , Adult , Analysis of Variance , Chlorhexidine/therapeutic use , Cross-Over Studies , Drug Combinations , Female , Fluorides, Topical/therapeutic use , Humans , Lactoferrin/therapeutic use , Lactoperoxidase/therapeutic use , Male , Muramidase/therapeutic use , Observer Variation , Patient Compliance , Single-Blind Method , Statistics, Nonparametric , Tin Fluorides/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...